Study of Pemetrexed+Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Participants With First Line Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-3475-189/KEYNOTE-189)-Japan Extension Study
Clinical trial NCT03950674 · COMPLETED
Trial details
- NCT number
- NCT03950674
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-22
- Primary completion
- 2019-05-20
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.